These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 37404599
1. Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan. Nashi M, Kishimoto H, Kobayashi M, Tachibana A, Suematsu M, Fujiwara S, Ota Y, Hashitani S, Shibatsuji T, Nishida T, Fujimura K, Furudoi S, Ishida Y, Ishii S, Fujita T, Iwai S, Shigeta T, Harada T, Miyai D, Takeda D, Akashi M, Noguchi K, Takenobu T. J Dent Sci; 2023 Jul; 18(3):1156-1163. PubMed ID: 37404599 [Abstract] [Full Text] [Related]
5. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series. Aljohani S, Gaudin R, Weiser J, Tröltzsch M, Ehrenfeld M, Kaeppler G, Smeets R, Otto S. J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309 [Abstract] [Full Text] [Related]
6. Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries. Taguchi A, Shiraki M, Morrison A, Khan AA. Osteoporos Sarcopenia; 2017 Jun; 3(2):64-74. PubMed ID: 30775507 [Abstract] [Full Text] [Related]
7. Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication). Baba A, Ojiri H, Goto TK, Ikeda K, Yamauchi H, Ogino N, Mogami T. Jpn Dent Sci Rev; 2019 Nov; 55(1):58-64. PubMed ID: 30815046 [Abstract] [Full Text] [Related]
8. [Current situation and future issues of antiresorptive agent-related osteonecrosis of the jaw]. Takaoka K, Kishimoto H. Nihon Yakurigaku Zasshi; 2019 Nov; 153(1):22-27. PubMed ID: 30643088 [Abstract] [Full Text] [Related]
9. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw. Assaf AT, Zrnc TA, Remus CC, Adam G, Zustin J, Heiland M, Friedrich RE, Derlin T. J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916 [Abstract] [Full Text] [Related]
10. Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. Japanese Allied Committee on Osteonecrosis of the Jaw, Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Nagata T, Urade M, Shibahara T, Toyosawa S. J Bone Miner Metab; 2017 Jan; 35(1):6-19. PubMed ID: 28035494 [Abstract] [Full Text] [Related]
13. Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice. Hayano H, Kuroshima S, Sasaki M, Tamaki S, Inoue M, Ishisaki A, Sawase T. Bone; 2020 Jun; 135():115308. PubMed ID: 32142911 [Abstract] [Full Text] [Related]
14. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis. Voss PJ, Steybe D, Poxleitner P, Schmelzeisen R, Munzenmayer C, Fuellgraf H, Stricker A, Semper-Hogg W. Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913 [Abstract] [Full Text] [Related]
17. Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage. Watanabe T, Asai K, Fukuhara S, Uozumi R, Bessho K. PLoS One; 2021 Oct; 16(1):e0244859. PubMed ID: 33395446 [Abstract] [Full Text] [Related]
18. Evaluation of Periodontal Space Widening in Patients with Antiresorptive Drug-related Osteonecrosis of the Jaws (ARONJ) on Panoramic Radiographs. Assaf AT, Amberg V, Smeets R, Wikner J, Hanken H, Semmusch J, Ewald F, Rashad A, Friedrich RE. Anticancer Res; 2018 Sep; 38(9):5305-5314. PubMed ID: 30194182 [Abstract] [Full Text] [Related]